Skip to main content

Advertisement

Log in

Central Lymph Node Dissection in Differentiated Thyroid Cancer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

There has been renewed interest in extensive lymph node dissection for papillary thyroid cancer (PTC), and a number of reports have been published concerning compartment-oriented dissection of regional lymph nodes in PTC. A comprehensive review of this body of literature using evidence-based methodology is pending.

Methods

Systematic review of the literature using evidence-based criteria.

Results

Issue 1: Systematic compartment-oriented central lymph node dissection (CLND) may decrease recurrence of PTC (Levels IV and V data, no recommendation) and likely improves disease-specific survival (grade C recommendation). Limited level III data suggest survival benefit with the addition of prophylactic dissection to thyroidectomy (grade C recommendation). The addition of CLND to total thyroidectomy can significantly reduce levels of serum thyroglobulin and increase rates of athyroglobulinemia (level IV data, no recommendation). Issue 2: There may be a higher rate of permanent hypoparathyroidism and unintentional permanent nerve injury when CLND is performed with total thyroidectomy than for total thyroidectomy alone (grade C recommendation). Issue 3: Reoperation in the central neck compartment for recurrent PTC may increase the risk of hypoparathyroidism and unintentional nerve injury when compared with total thyroidectomy with or without CLND (grade C recommendation), supporting a more aggressive initial operation.

Conclusion

Evidence-based recommendations support CLND for PTC in patients under the care of experienced endocrine surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sherman SI. Thyroid carcinoma. Lancet 2003;361:501–511.

    Article  PubMed  Google Scholar 

  2. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–142.

    Article  PubMed  Google Scholar 

  3. Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997;82:1638–1641.

    Article  CAS  PubMed  Google Scholar 

  4. Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22–28.

    Article  PubMed  Google Scholar 

  5. Hamming JF, Roukema JA. Management of regional lymph nodes in papillary, follicular, and medullary thyroid cancer. In: Clark OH, Duh Q-Y, Kebebew E, editors. Textbook of endocrine surgery, 2nd ed. Philadelphia, Saunders, 2005, pp 195–206

    Google Scholar 

  6. Qubain SW, Nakano S, Baba M, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002;131:249–256.

    Article  PubMed  Google Scholar 

  7. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998;85:252–254.

    Article  CAS  PubMed  Google Scholar 

  8. Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004;139:43–45.

    Article  PubMed  Google Scholar 

  9. Gauger PG. Thyroid gland. In: Mulholland MW, Lillemoe KD, Doherty GM, editors. Greenfield’s Surgery: Scientific Principles and Practice, 4th ed. Philadelphia, Lippincott Williams & Wilkins, 2006, pp. 1289–1309

    Google Scholar 

  10. Henry JF, Gramatica L, Denizot A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998;383:167–169.

    CAS  PubMed  Google Scholar 

  11. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005;138:1095–1100; discussion 1100–1101.

    Article  PubMed  Google Scholar 

  12. Shindo M, Wu JC, Park EE, et al. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006;132:650–654.

    Article  PubMed  Google Scholar 

  13. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003;237:399–407.

    Article  PubMed  Google Scholar 

  14. Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567; discussion 567–558.

    Article  CAS  PubMed  Google Scholar 

  15. Robbins KT, Medina JE, Wolfe GT, et al. Standardizing neck dissection terminology. Official report of the Academy’s Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601–605.

    CAS  PubMed  Google Scholar 

  16. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751–758.

    PubMed  Google Scholar 

  17. Tisell LE, Hansson G, Jansson S, et al. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986;99:60–66.

    CAS  PubMed  Google Scholar 

  18. Moley JF, Wells SA. Compartment-mediated dissection for papillary thyroid cancer. Langenbecks Arch Surg 1999;384:9–15.

    Article  CAS  PubMed  Google Scholar 

  19. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95:2S–4S.

    CAS  PubMed  Google Scholar 

  20. Rossi RL, Cady B, Silverman ML, et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612–622.

    Article  CAS  PubMed  Google Scholar 

  21. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418–428.

    Article  CAS  PubMed  Google Scholar 

  22. Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996;18:127–132.

    Article  CAS  PubMed  Google Scholar 

  23. Cady B, Sedgwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810–820.

    Article  CAS  PubMed  Google Scholar 

  24. Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088–1095.

    CAS  PubMed  Google Scholar 

  25. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050–1057; discussion 1057–1058.

    CAS  PubMed  Google Scholar 

  26. Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006;106:524–531.

    Article  PubMed  Google Scholar 

  27. Heinrich S, Schafer M, Rousson V, et al. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006;243:154–168.

    Article  PubMed  Google Scholar 

  28. Tisell LE, Nilsson B, Molne J, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996;20:854–859.

    Article  CAS  PubMed  Google Scholar 

  29. Shah MD, Hall FT, Eski SJ, et al. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003;113:2102–2107.

    Article  PubMed  Google Scholar 

  30. Steinmuller T, Klupp J, Rayes N, et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000;166:29–33.

    Article  CAS  PubMed  Google Scholar 

  31. Noguchi S, Murakami N, Yamashita H, et al. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch Surg 1998;133:276–280.

    Article  CAS  PubMed  Google Scholar 

  32. Simon D, Goretzki PE, Witte J, et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860–866; discussion 866.

    Article  CAS  PubMed  Google Scholar 

  33. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005;90:5723–5729.

    Article  CAS  PubMed  Google Scholar 

  34. Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 1998;83:553–559.

    Article  CAS  PubMed  Google Scholar 

  35. Sato N, Oyamatsu M, Koyama Y, et al. Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 1998;69:151–155.

    Article  CAS  PubMed  Google Scholar 

  36. Ito Y, Jikuzono T, Higashiyama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821–1828.

    Article  PubMed  Google Scholar 

  37. Sywak M, Cornford L, Roach P, et al. Routine level six lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1000–1005; discussion 1005–1007.

    Article  PubMed  Google Scholar 

  38. Clark OH, Levin K, Zeng QH, et al. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin Oncol 1988;24:305–313.

    Article  CAS  PubMed  Google Scholar 

  39. Ley PB, Roberts JW, Symmonds RE Jr, et al. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review. Am Surg 1993;59:110–114.

    CAS  PubMed  Google Scholar 

  40. Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004;28:271–276.

    Article  PubMed  Google Scholar 

  41. Gemsenjager E, Perren A, Seifert B, et al. Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 2003;197:182–190.

    Article  PubMed  Google Scholar 

  42. Steinmuller T, Klupp J, Wenking S, et al. Complications associated with different surgical approaches to differentiated thyroid carcinoma. Langenbecks Arch Surg 1999;384:50–53.

    Article  CAS  PubMed  Google Scholar 

  43. Goropoulos A, Karamoshos K, Christodoulou A, et al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World J Surg 2004;28:1275–1281.

    Article  PubMed  Google Scholar 

  44. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2006;30:91–99.

    Article  PubMed  Google Scholar 

  45. Segal K, Friedental R, Lubin E, et al. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 1995;113:356–363.

    Article  CAS  PubMed  Google Scholar 

  46. Moley JF, Lairmore TC, Doherty GM, et al. Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 1999;126:673–677; discussion 677–679.

    CAS  PubMed  Google Scholar 

  47. Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004;130:1214–1216.

    Article  PubMed  Google Scholar 

  48. Uruno T, Miyauchi A, Shimizu K, et al. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today 2004;34:891–895.

    Article  PubMed  Google Scholar 

  49. Kouvaraki MA, Lee JE, Shapiro SE, et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 2004;136:1183–1191.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerard M. Doherty MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

White, M.L., Gauger, P.G. & Doherty, G.M. Central Lymph Node Dissection in Differentiated Thyroid Cancer. World J Surg 31, 895–904 (2007). https://doi.org/10.1007/s00268-006-0907-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-006-0907-6

Keywords

Navigation